# Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Labor

> **NCT05742997** · NA · UNKNOWN · sponsor: **Ziekenhuis Oost-Limburg** · enrollment: 165 (estimated)

## Conditions studied

- Preterm Birth

## Interventions

- **DEVICE:** PartoSure
- **DEVICE:** Fetal Fibronectine

## Key facts

- **NCT ID:** NCT05742997
- **Lead sponsor:** Ziekenhuis Oost-Limburg
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742997, "Evaluation of a Novel Diagnostic Kit for the Detection of Placental Alpha-Microglobulin-1 in the Prediction of Preterm Birth in Women Presenting With Signs and Symptoms of Preterm Labor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05742997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*